Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-13
2007-02-13
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
10824034
ABSTRACT:
This invention relates to the enantiomers of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one, prodrugs thereof, and pharmaceutically acceptable salts and solvates of said compounds and said prodrugs, that are useful in the treatment of hyperproliferative diseases, such as cancers, in mammals. The invention also relates to processes for the production of enantiomerically pure or optically enriched (+)- or (−)-6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one enantiomers from a mixture containing two enantiomers using continuous chromatography. The invention further relates to the L-(+)-tartaric acid or (S)-(−)-1,1′-binapthyl-2,2′-diyl hydrogenphosphate salts of (+)-6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-[3-(3-hydroxy-3-methyl-but-1-ynyl)-phenyl]-1-methyl-1H-quinolin-2-one.
REFERENCES:
patent: 5747498 (1998-05-01), Schnur et al.
patent: 5968952 (1999-10-01), Venet et al.
patent: 6037350 (2000-03-01), Venet et al.
patent: 6040334 (2000-03-01), Myers et al.
patent: 6071935 (2000-06-01), Lyssikatos
patent: 6083985 (2000-07-01), Yonemoto et al.
patent: 6150377 (2000-11-01), Lyssikatos et al.
patent: 6444854 (2002-09-01), Dapremont et al.
patent: 6740757 (2004-05-01), Guinn et al.
patent: 0856315 (1996-08-01), None
patent: 9705902 (1997-02-01), None
patent: 9716443 (1997-05-01), None
patent: 9721701 (1997-06-01), None
patent: 9857633 (1998-12-01), None
patent: 0016778 (2000-03-01), None
Ewing Marcus Douglas
Guhan Subramanian Sam
Guinn R. Mark
Li Bryan
Meltz Clifford N.
Pfizer Inc
Seaman D. Margaret
Smolizza Christian M.
Zelson Steve T.
LandOfFree
Enantiomers of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enantiomers of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomers of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3867013